Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure

Short bowel syndrome (SBS) with intestinal failure (IF) is a rare but severe complication of Crohn’s disease (CD), which is the most frequent benign condition that leads to SBS after repeated surgical resections, even in the era of biologics and small molecules. Glucagon-like peptide-2 analogues hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzoferrato, Marco, Puca, Pierluigi, Ennas, Sara, Cammarota, Giovanni, Guidi, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730438/
https://www.ncbi.nlm.nih.gov/pubmed/36504557
http://dx.doi.org/10.3748/wjg.v28.i44.6258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730438/
https://www.ncbi.nlm.nih.gov/pubmed/36504557
http://dx.doi.org/10.3748/wjg.v28.i44.6258

Ejemplares similares